Nominate: Xconomy Awards →
May 13, 2020 · Boston
June 11, 2020 · New York
June 25, 2020 · San Francisco
Esperion, a biotech startup located in Plymouth, MI, is developing cholesterol-lowering drugs that are an alternative to statins.
From Our Editors · Special Report
Key indicators & expert insight from industry leaders
Sponsored · Whitepaper
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.